Gene Symbol | Gene ID | Gene Info |
---|---|---|
Onecut1
|
ENSMUSG00000043013.9 | one cut domain, family member 1 |
Cux2
|
ENSMUSG00000042589.12 | cut-like homeobox 2 |
Cux2
|
ENSMUSG00000072641.1 | cut-like homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_121950319_121950485 | Cux2 | 25481 | 0.148843 | 0.80 | 1.4e-13 | Click! |
chr5_121981639_121982165 | Cux2 | 20442 | 0.153629 | -0.51 | 7.4e-05 | Click! |
chr5_122003586_122003738 | Cux2 | 1318 | 0.401890 | 0.48 | 2.0e-04 | Click! |
chr5_121938414_121938693 | Cux2 | 13632 | 0.170147 | -0.48 | 2.4e-04 | Click! |
chr5_121992006_121992157 | Cux2 | 10263 | 0.167545 | 0.47 | 3.2e-04 | Click! |
chr9_74864646_74864819 | Onecut1 | 1752 | 0.290136 | 0.60 | 1.3e-06 | Click! |
chr9_74866336_74866487 | Onecut1 | 73 | 0.964730 | 0.54 | 1.7e-05 | Click! |
chr9_74866734_74867275 | Onecut1 | 520 | 0.734208 | 0.54 | 2.2e-05 | Click! |
chr9_74866498_74866655 | Onecut1 | 92 | 0.960978 | 0.51 | 7.8e-05 | Click! |
chr9_74909357_74909519 | Onecut1 | 42954 | 0.108933 | -0.48 | 2.4e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_123196731_123197228 | 63.14 |
Gm43409 |
predicted gene 43409 |
5391 |
0.11 |
chr6_38929161_38929494 | 47.83 |
Tbxas1 |
thromboxane A synthase 1, platelet |
10303 |
0.2 |
chr3_131283448_131283608 | 38.53 |
Gm18492 |
predicted gene, 18492 |
1616 |
0.31 |
chr15_67013557_67013852 | 35.20 |
Gm31342 |
predicted gene, 31342 |
26354 |
0.16 |
chr19_46668309_46668590 | 34.54 |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
1064 |
0.36 |
chr6_128631293_128631482 | 34.43 |
Klrb1a |
killer cell lectin-like receptor subfamily B member 1A |
7854 |
0.08 |
chrX_139596463_139596745 | 34.27 |
Rnf128 |
ring finger protein 128 |
14016 |
0.22 |
chr1_80428054_80428206 | 33.24 |
1700016L21Rik |
RIKEN cDNA 1700016L21 gene |
17802 |
0.15 |
chr12_13002798_13003108 | 33.12 |
Gm35208 |
predicted gene, 35208 |
15636 |
0.16 |
chr17_15031604_15031783 | 32.96 |
Ermard |
ER membrane associated RNA degradation |
9515 |
0.12 |
chr11_110462881_110463221 | 32.77 |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
14326 |
0.27 |
chr17_14968636_14968823 | 32.60 |
Phf10 |
PHD finger protein 10 |
7456 |
0.11 |
chr3_28682061_28682242 | 32.18 |
Tnik |
TRAF2 and NCK interacting kinase |
15305 |
0.17 |
chr15_9472719_9472904 | 32.15 |
Gm50456 |
predicted gene, 50456 |
2691 |
0.29 |
chr17_15000217_15000406 | 31.99 |
Gm3448 |
predicted gene 3448 |
9858 |
0.11 |
chr13_41236169_41236337 | 31.80 |
Gm32063 |
predicted gene, 32063 |
92 |
0.93 |
chr15_101922406_101922557 | 31.37 |
Krt4 |
keratin 4 |
2254 |
0.16 |
chr3_10285988_10286139 | 31.17 |
Fabp12 |
fatty acid binding protein 12 |
15111 |
0.09 |
chr1_184645271_184645605 | 29.66 |
Gm37800 |
predicted gene, 37800 |
15965 |
0.15 |
chr14_122651733_122652067 | 29.06 |
Gm49260 |
predicted gene, 49260 |
34416 |
0.15 |
chr16_49896195_49896504 | 28.80 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
29516 |
0.24 |
chr2_127370733_127370986 | 28.70 |
Adra2b |
adrenergic receptor, alpha 2b |
7573 |
0.15 |
chr13_35959790_35959969 | 28.10 |
Ppp1r3g |
protein phosphatase 1, regulatory subunit 3G |
1040 |
0.4 |
chr1_137010612_137010841 | 27.41 |
Gm23763 |
predicted gene, 23763 |
20456 |
0.22 |
chr9_115403468_115403626 | 26.85 |
Gm9487 |
predicted gene 9487 |
1602 |
0.28 |
chr12_80909830_80909997 | 26.83 |
Gm23298 |
predicted gene, 23298 |
1564 |
0.3 |
chr10_12643418_12643569 | 26.70 |
Utrn |
utrophin |
28662 |
0.23 |
chr16_87524276_87524427 | 26.60 |
Gm24891 |
predicted gene, 24891 |
3814 |
0.16 |
chr3_154193534_154193819 | 26.50 |
Slc44a5 |
solute carrier family 44, member 5 |
28806 |
0.16 |
chr2_147944293_147944444 | 26.28 |
9030622O22Rik |
RIKEN cDNA 9030622O22 gene |
31817 |
0.18 |
chr6_128755122_128755308 | 25.75 |
Gm43907 |
predicted gene, 43907 |
10571 |
0.11 |
chr7_133563596_133563762 | 25.54 |
Tex36 |
testis expressed 36 |
38479 |
0.12 |
chr6_17578454_17578676 | 25.33 |
Met |
met proto-oncogene |
31592 |
0.17 |
chr2_72179925_72180079 | 25.03 |
Rapgef4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
309 |
0.9 |
chr19_24794066_24794366 | 24.88 |
Pgm5 |
phosphoglucomutase 5 |
31138 |
0.16 |
chr12_71355219_71355529 | 24.56 |
Gm40438 |
predicted gene, 40438 |
67 |
0.97 |
chr6_125565069_125565345 | 24.48 |
Vwf |
Von Willebrand factor |
1044 |
0.56 |
chr17_71235938_71236335 | 24.44 |
Lpin2 |
lipin 2 |
2526 |
0.24 |
chr9_70926583_70926742 | 24.42 |
Gm32017 |
predicted gene, 32017 |
3826 |
0.24 |
chr6_135199416_135199582 | 24.40 |
Fam234b |
family with sequence similarity 234, member B |
1087 |
0.32 |
chr5_135115423_135115665 | 24.36 |
Gm43500 |
predicted gene 43500 |
7749 |
0.1 |
chr18_7132506_7132797 | 24.33 |
4930415O11Rik |
RIKEN cDNA 4930415O11 gene |
19126 |
0.18 |
chr18_39430712_39430884 | 24.28 |
Gm15337 |
predicted gene 15337 |
41373 |
0.15 |
chr12_110871328_110871603 | 24.02 |
Cinp |
cyclin-dependent kinase 2 interacting protein |
5879 |
0.1 |
chr5_90414232_90414383 | 24.01 |
Gm43363 |
predicted gene 43363 |
17034 |
0.15 |
chr12_80976041_80976212 | 23.87 |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
7421 |
0.15 |
chr1_79466636_79466862 | 23.58 |
Scg2 |
secretogranin II |
26629 |
0.18 |
chr3_27918693_27919016 | 23.52 |
Pld1 |
phospholipase D1 |
19841 |
0.19 |
chr1_16310084_16310238 | 23.12 |
Gm7568 |
predicted gene 7568 |
56532 |
0.12 |
chr13_110425640_110425813 | 22.98 |
Plk2 |
polo like kinase 2 |
27929 |
0.22 |
chr11_31831040_31831254 | 22.60 |
Gm12107 |
predicted gene 12107 |
1513 |
0.4 |
chr7_14438643_14438820 | 22.54 |
Sult2a8 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 8 |
170 |
0.94 |
chr4_156253105_156253431 | 22.37 |
Samd11 |
sterile alpha motif domain containing 11 |
873 |
0.35 |
chr3_146591279_146591570 | 22.15 |
Dnase2b |
deoxyribonuclease II beta |
5188 |
0.14 |
chr5_45534407_45534776 | 22.03 |
Fam184b |
family with sequence similarity 184, member B |
1951 |
0.21 |
chr18_56392878_56393029 | 21.90 |
Gm8629 |
predicted gene 8629 |
2810 |
0.27 |
chr2_166246513_166246665 | 21.73 |
Gm11468 |
predicted gene 11468 |
27319 |
0.15 |
chr14_64193921_64194220 | 21.18 |
9630015K15Rik |
RIKEN cDNA 9630015K15 gene |
77756 |
0.08 |
chr1_178330123_178330310 | 21.09 |
Hnrnpu |
heterogeneous nuclear ribonucleoprotein U |
104 |
0.94 |
chr3_97844515_97844666 | 21.02 |
Pde4dip |
phosphodiesterase 4D interacting protein (myomegalin) |
19969 |
0.17 |
chr1_190204507_190204674 | 20.77 |
Prox1 |
prospero homeobox 1 |
33876 |
0.16 |
chr13_111656412_111656573 | 20.63 |
Mier3 |
MIER family member 3 |
24487 |
0.13 |
chr6_57514001_57514319 | 20.59 |
Ppm1k |
protein phosphatase 1K (PP2C domain containing) |
1447 |
0.34 |
chr7_13814030_13814212 | 20.56 |
Kat6b-ps2 |
k(lysine) acetyltransferase 6B, pseudogene 2 |
921 |
0.49 |
chr4_11147050_11147201 | 20.55 |
Gm11830 |
predicted gene 11830 |
2415 |
0.18 |
chr1_190129647_190129862 | 20.44 |
Gm28172 |
predicted gene 28172 |
38916 |
0.15 |
chr2_19796878_19797044 | 20.40 |
Gm44457 |
predicted gene, 44457 |
91692 |
0.06 |
chr9_107674742_107674900 | 20.40 |
Gnat1 |
guanine nucleotide binding protein, alpha transducing 1 |
1620 |
0.18 |
chr3_37201245_37201407 | 20.40 |
Gm12532 |
predicted gene 12532 |
18441 |
0.11 |
chr19_56278496_56278647 | 20.37 |
Gm22271 |
predicted gene, 22271 |
926 |
0.6 |
chr2_161944692_161944973 | 20.35 |
Ptprt |
protein tyrosine phosphatase, receptor type, T |
144677 |
0.05 |
chr3_28725362_28725519 | 20.14 |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
3923 |
0.19 |
chr7_99206451_99206675 | 20.02 |
Gm45012 |
predicted gene 45012 |
4197 |
0.15 |
chr17_85052566_85052751 | 19.96 |
Slc3a1 |
solute carrier family 3, member 1 |
24282 |
0.15 |
chr1_76911556_76911707 | 19.94 |
Gm816 |
predicted gene 816 |
116161 |
0.07 |
chr10_111608769_111608920 | 19.91 |
Gm30262 |
predicted gene, 30262 |
9667 |
0.16 |
chr9_57287286_57287473 | 19.91 |
1700017B05Rik |
RIKEN cDNA 1700017B05 gene |
24767 |
0.13 |
chr6_67034912_67035078 | 19.80 |
E230016M11Rik |
RIKEN cDNA E230016M11 gene |
1604 |
0.23 |
chr11_32295762_32295913 | 19.71 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
652 |
0.55 |
chr18_84906326_84906549 | 19.63 |
Fbxo15 |
F-box protein 15 |
28345 |
0.13 |
chr16_4100574_4100725 | 19.51 |
Crebbp |
CREB binding protein |
4523 |
0.15 |
chr15_39813498_39813734 | 19.45 |
Gm16291 |
predicted gene 16291 |
16571 |
0.19 |
chr1_87648753_87648925 | 19.45 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
27165 |
0.14 |
chr1_163338944_163339281 | 19.42 |
Prrx1 |
paired related homeobox 1 |
25402 |
0.15 |
chr4_118544903_118545098 | 19.40 |
Tmem125 |
transmembrane protein 125 |
956 |
0.42 |
chr14_41096371_41096522 | 19.33 |
Mat1a |
methionine adenosyltransferase I, alpha |
8589 |
0.12 |
chr2_85096089_85096248 | 19.24 |
4930443O20Rik |
RIKEN cDNA 4930443O20 gene |
9707 |
0.12 |
chr10_128336232_128336487 | 19.23 |
Cs |
citrate synthase |
1375 |
0.18 |
chr15_78831812_78831972 | 19.12 |
Cdc42ep1 |
CDC42 effector protein (Rho GTPase binding) 1 |
10732 |
0.09 |
chr10_128790514_128790671 | 19.10 |
Mmp19 |
matrix metallopeptidase 19 |
318 |
0.75 |
chr15_85330144_85330310 | 19.07 |
Atxn10 |
ataxin 10 |
6018 |
0.21 |
chr3_27904997_27905236 | 18.98 |
Tmem212 |
transmembrane protein 212 |
8748 |
0.22 |
chr8_106597223_106597388 | 18.86 |
Cdh1 |
cadherin 1 |
6046 |
0.17 |
chr7_25052709_25052879 | 18.69 |
Grik5 |
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
6637 |
0.12 |
chr13_97439179_97439838 | 18.37 |
Lncenc1 |
long non-coding RNA, embryonic stem cells expressed 1 |
4538 |
0.2 |
chr12_59018104_59018321 | 18.34 |
Gemin2 |
gem nuclear organelle associated protein 2 |
4758 |
0.14 |
chr13_114462916_114463104 | 18.27 |
Fst |
follistatin |
4059 |
0.18 |
chr14_63231380_63231561 | 18.22 |
Gata4 |
GATA binding protein 4 |
13778 |
0.16 |
chr13_81663841_81663992 | 18.16 |
Lysmd3 |
LysM, putative peptidoglycan-binding, domain containing 3 |
1278 |
0.42 |
chr11_78294708_78294859 | 18.01 |
Gm3948 |
predicted gene 3948 |
827 |
0.3 |
chr9_61314723_61314909 | 17.70 |
B930092H01Rik |
RIKEN cDNA B930092H01 gene |
21007 |
0.18 |
chr5_149096367_149096606 | 17.68 |
Mm2pr |
macrophage M2 polarization regulator |
26926 |
0.09 |
chr8_67570409_67570727 | 17.60 |
Gm36247 |
predicted gene, 36247 |
14622 |
0.18 |
chr4_119190676_119190850 | 17.60 |
Ermap |
erythroblast membrane-associated protein |
752 |
0.43 |
chrX_101370598_101370882 | 17.45 |
Gjb1 |
gap junction protein, beta 1 |
5638 |
0.15 |
chr8_117796538_117796693 | 17.44 |
Mphosph6 |
M phase phosphoprotein 6 |
3398 |
0.22 |
chr19_59906485_59906636 | 17.44 |
Gm17203 |
predicted gene 17203 |
5498 |
0.23 |
chr4_6914500_6914700 | 17.41 |
Tox |
thymocyte selection-associated high mobility group box |
75883 |
0.12 |
chr13_63326182_63326333 | 17.39 |
Fancc |
Fanconi anemia, complementation group C |
1239 |
0.27 |
chr19_37442831_37443030 | 17.29 |
Hhex |
hematopoietically expressed homeobox |
6191 |
0.13 |
chr12_105055420_105055592 | 17.28 |
Glrx5 |
glutaredoxin 5 |
20290 |
0.1 |
chr12_21265061_21265212 | 17.15 |
Itgb1bp1 |
integrin beta 1 binding protein 1 |
6987 |
0.12 |
chr19_42722452_42722956 | 17.11 |
Gm25216 |
predicted gene, 25216 |
22802 |
0.13 |
chr7_119620199_119620358 | 17.09 |
Gm19950 |
predicted gene, 19950 |
19 |
0.96 |
chr16_76319178_76320114 | 17.03 |
Nrip1 |
nuclear receptor interacting protein 1 |
4012 |
0.29 |
chr1_86175540_86175691 | 17.00 |
Armc9 |
armadillo repeat containing 9 |
20775 |
0.12 |
chr12_91745616_91746448 | 16.99 |
Ston2 |
stonin 2 |
52 |
0.97 |
chr5_8873304_8873464 | 16.97 |
Abcb4 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
20333 |
0.13 |
chr15_62233279_62233430 | 16.95 |
Pvt1 |
Pvt1 oncogene |
10751 |
0.24 |
chr1_133798500_133798871 | 16.91 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
2351 |
0.22 |
chr2_170086590_170086741 | 16.90 |
Zfp217 |
zinc finger protein 217 |
44555 |
0.18 |
chr7_81587259_81587432 | 16.83 |
Gm45698 |
predicted gene 45698 |
3549 |
0.13 |
chr1_137172255_137172406 | 16.82 |
Gm25609 |
predicted gene, 25609 |
43317 |
0.17 |
chr7_29030418_29030583 | 16.79 |
Gm38979 |
predicted gene, 38979 |
1477 |
0.24 |
chr8_22475110_22475268 | 16.76 |
Slc20a2 |
solute carrier family 20, member 2 |
1599 |
0.23 |
chr2_11713131_11713305 | 16.76 |
Il15ra |
interleukin 15 receptor, alpha chain |
5109 |
0.17 |
chr11_86376812_86376994 | 16.73 |
Med13 |
mediator complex subunit 13 |
19301 |
0.17 |
chr11_44508913_44509245 | 16.70 |
Rnf145 |
ring finger protein 145 |
9885 |
0.16 |
chr15_83423308_83423476 | 16.68 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
398 |
0.82 |
chr12_3286042_3286208 | 16.68 |
Rab10 |
RAB10, member RAS oncogene family |
23844 |
0.14 |
chr10_118700136_118700422 | 16.62 |
Gm33337 |
predicted gene, 33337 |
15447 |
0.18 |
chr14_21590305_21590456 | 16.59 |
Kat6b |
K(lysine) acetyltransferase 6B |
32162 |
0.19 |
chr3_144583926_144584077 | 16.57 |
Gm24406 |
predicted gene, 24406 |
2951 |
0.19 |
chr4_137527404_137527717 | 16.43 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
5101 |
0.17 |
chr14_120762214_120762400 | 16.30 |
Gm17613 |
predicted gene, 17613 |
13122 |
0.16 |
chr10_122515778_122515949 | 16.30 |
Gm48877 |
predicted gene, 48877 |
30635 |
0.16 |
chr1_131447455_131447629 | 16.26 |
Gm29487 |
predicted gene 29487 |
153 |
0.95 |
chr2_94177420_94177571 | 16.26 |
Mir670hg |
MIR670 host gene (non-protein coding) |
1420 |
0.36 |
chr11_103867830_103867981 | 16.22 |
Nsf |
N-ethylmaleimide sensitive fusion protein |
4295 |
0.22 |
chr11_100747198_100747368 | 16.18 |
Rab5c |
RAB5C, member RAS oncogene family |
9068 |
0.09 |
chr4_63154154_63154364 | 16.12 |
Ambp |
alpha 1 microglobulin/bikunin precursor |
86 |
0.97 |
chr11_110037944_110038095 | 15.97 |
Abca8a |
ATP-binding cassette, sub-family A (ABC1), member 8a |
7938 |
0.24 |
chr2_60410183_60410334 | 15.93 |
Gm13580 |
predicted gene 13580 |
1267 |
0.43 |
chr15_102026499_102026806 | 15.89 |
Krt18 |
keratin 18 |
1528 |
0.27 |
chr2_26600603_26600909 | 15.87 |
Agpat2 |
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) |
2960 |
0.12 |
chr5_123854595_123854839 | 15.85 |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
10782 |
0.13 |
chr1_74910345_74910496 | 15.81 |
Gm15841 |
predicted gene 15841 |
8049 |
0.1 |
chr3_146271120_146271271 | 15.77 |
Lpar3 |
lysophosphatidic acid receptor 3 |
50232 |
0.11 |
chr4_108233340_108233491 | 15.76 |
Zyg11b |
zyg-ll family member B, cell cycle regulator |
8623 |
0.16 |
chr15_10379905_10380056 | 15.75 |
Agxt2 |
alanine-glyoxylate aminotransferase 2 |
21401 |
0.18 |
chr3_98242565_98242982 | 15.68 |
Gm42821 |
predicted gene 42821 |
5826 |
0.16 |
chr2_164421422_164421573 | 15.67 |
Matn4 |
matrilin 4 |
16337 |
0.08 |
chr9_109125593_109125744 | 15.64 |
Plxnb1 |
plexin B1 |
18874 |
0.1 |
chr19_16184045_16184325 | 15.63 |
E030024N20Rik |
RIKEN cDNA E030024N20 gene |
19380 |
0.19 |
chr11_84822520_84822812 | 15.63 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
3151 |
0.16 |
chr11_87984677_87984828 | 15.56 |
Dynll2 |
dynein light chain LC8-type 2 |
740 |
0.57 |
chr1_160374590_160374741 | 15.50 |
Rabgap1l |
RAB GTPase activating protein 1-like |
23094 |
0.16 |
chr14_64658081_64658232 | 15.44 |
Kif13b |
kinesin family member 13B |
5554 |
0.22 |
chr13_74484403_74484581 | 15.42 |
Zfp825 |
zinc finger protein 825 |
1549 |
0.23 |
chr17_72399784_72399958 | 15.40 |
Gm24736 |
predicted gene, 24736 |
99547 |
0.08 |
chr13_55426755_55426906 | 15.37 |
F12 |
coagulation factor XII (Hageman factor) |
37 |
0.95 |
chr3_95643066_95643217 | 15.32 |
E330034L11Rik |
RIKEN cDNA E330034L11 gene |
3837 |
0.12 |
chr4_150461962_150462133 | 15.30 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
26346 |
0.21 |
chr9_71137940_71138091 | 15.25 |
Gm47268 |
predicted gene, 47268 |
11173 |
0.18 |
chr14_65648641_65648792 | 15.16 |
Scara5 |
scavenger receptor class A, member 5 |
17687 |
0.2 |
chr2_79762768_79763048 | 15.07 |
Ppp1r1c |
protein phosphatase 1, regulatory inhibitor subunit 1C |
23683 |
0.25 |
chr13_109380330_109380481 | 15.07 |
Mir582 |
microRNA 582 |
55661 |
0.16 |
chr6_144967674_144967825 | 15.07 |
Bcat1 |
branched chain aminotransferase 1, cytosolic |
65094 |
0.09 |
chr16_94508853_94509130 | 15.05 |
Vps26c |
VPS26 endosomal protein sorting factor C |
4604 |
0.19 |
chr15_59043893_59044048 | 14.95 |
Mtss1 |
MTSS I-BAR domain containing 1 |
3373 |
0.28 |
chr6_38959498_38959807 | 14.95 |
Tbxas1 |
thromboxane A synthase 1, platelet |
12213 |
0.18 |
chr16_38286533_38286684 | 14.94 |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
8216 |
0.15 |
chr3_27751571_27751754 | 14.94 |
Fndc3b |
fibronectin type III domain containing 3B |
40355 |
0.19 |
chr4_107899249_107899588 | 14.93 |
Czib |
CXXC motif containing zinc binding protein |
6048 |
0.13 |
chr6_148917669_148917960 | 14.92 |
Gm43913 |
predicted gene, 43913 |
2721 |
0.15 |
chr17_80271212_80271363 | 14.90 |
Dhx57 |
DEAH (Asp-Glu-Ala-Asp/His) box polypeptide 57 |
704 |
0.59 |
chr3_19962855_19963059 | 14.89 |
Cp |
ceruloplasmin |
5673 |
0.19 |
chr6_121346538_121346717 | 14.86 |
Slc6a12 |
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
9 |
0.97 |
chr6_71236810_71236961 | 14.80 |
Smyd1 |
SET and MYND domain containing 1 |
20011 |
0.1 |
chrX_42012827_42012989 | 14.77 |
Xiap |
X-linked inhibitor of apoptosis |
46771 |
0.13 |
chr18_63952687_63952838 | 14.71 |
Gm24384 |
predicted gene, 24384 |
43606 |
0.15 |
chr16_78260390_78260785 | 14.70 |
E330011O21Rik |
RIKEN cDNA E330011O21 gene |
5365 |
0.17 |
chr18_12810237_12810595 | 14.69 |
Osbpl1a |
oxysterol binding protein-like 1A |
9182 |
0.18 |
chr6_67089634_67089785 | 14.67 |
E230016M11Rik |
RIKEN cDNA E230016M11 gene |
12949 |
0.14 |
chr10_30132527_30132678 | 14.67 |
Gm2829 |
predicted gene 2829 |
47124 |
0.13 |
chr6_93828431_93828582 | 14.66 |
Gm23035 |
predicted gene, 23035 |
34734 |
0.17 |
chr7_93019538_93019700 | 14.60 |
Gm26862 |
predicted gene, 26862 |
12637 |
0.18 |
chr10_87546434_87546625 | 14.51 |
Pah |
phenylalanine hydroxylase |
144 |
0.97 |
chr17_83567513_83567690 | 14.49 |
Cox7a2l |
cytochrome c oxidase subunit 7A2 like |
50271 |
0.14 |
chr4_118227479_118227826 | 14.49 |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
3448 |
0.21 |
chr10_93945938_93946139 | 14.48 |
Mir331 |
microRNA 331 |
17825 |
0.11 |
chr4_109467814_109467980 | 14.44 |
Rnf11 |
ring finger protein 11 |
8778 |
0.18 |
chr16_91717533_91717685 | 14.42 |
Cryzl1 |
crystallin, zeta (quinone reductase)-like 1 |
140 |
0.94 |
chr8_84970999_84971304 | 14.41 |
Prdx2 |
peroxiredoxin 2 |
305 |
0.66 |
chr13_19127362_19127551 | 14.41 |
Amph |
amphiphysin |
7667 |
0.21 |
chr5_126954321_126954472 | 14.40 |
Gm42955 |
predicted gene 42955 |
65831 |
0.11 |
chr17_56612629_56612869 | 14.38 |
Rpl36 |
ribosomal protein L36 |
667 |
0.51 |
chr1_184675628_184676155 | 14.38 |
Gm38358 |
predicted gene, 38358 |
19143 |
0.14 |
chr5_102556035_102556186 | 14.37 |
1700013M08Rik |
RIKEN cDNA 1700013M08 gene |
72821 |
0.11 |
chr11_79568640_79568791 | 14.36 |
Nf1 |
neurofibromin 1 |
22407 |
0.09 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 20.3 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
5.1 | 15.2 | GO:0045472 | response to ether(GO:0045472) |
4.9 | 14.8 | GO:0002254 | kinin cascade(GO:0002254) |
4.3 | 12.9 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
4.2 | 20.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
3.9 | 11.8 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
3.9 | 15.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
3.9 | 15.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
3.8 | 11.5 | GO:0008228 | opsonization(GO:0008228) |
3.8 | 11.4 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
3.6 | 10.8 | GO:0035524 | proline transmembrane transport(GO:0035524) |
3.6 | 24.9 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
3.5 | 21.0 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
3.4 | 13.6 | GO:0035482 | gastric motility(GO:0035482) |
3.4 | 10.2 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
3.4 | 10.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
3.3 | 9.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
3.3 | 16.4 | GO:0070836 | caveola assembly(GO:0070836) |
3.1 | 21.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
3.0 | 9.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
3.0 | 12.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
3.0 | 9.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
3.0 | 29.6 | GO:0042448 | progesterone metabolic process(GO:0042448) |
2.9 | 11.7 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
2.9 | 8.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.7 | 8.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.7 | 15.9 | GO:0006642 | triglyceride mobilization(GO:0006642) |
2.6 | 7.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
2.6 | 7.7 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
2.5 | 7.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
2.4 | 7.3 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
2.4 | 9.4 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
2.3 | 14.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
2.3 | 7.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
2.3 | 11.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
2.3 | 2.3 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
2.3 | 4.6 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
2.3 | 9.0 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
2.3 | 6.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
2.1 | 14.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
2.1 | 10.6 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
2.1 | 10.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
2.1 | 16.8 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
2.0 | 9.8 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.9 | 5.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.9 | 3.9 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.9 | 17.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.9 | 5.7 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.9 | 7.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
1.9 | 5.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.8 | 7.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
1.7 | 12.2 | GO:0097264 | self proteolysis(GO:0097264) |
1.7 | 5.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.7 | 17.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
1.7 | 1.7 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
1.7 | 5.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.7 | 8.4 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
1.7 | 8.4 | GO:0060374 | mast cell differentiation(GO:0060374) |
1.7 | 1.7 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.7 | 5.0 | GO:0006868 | glutamine transport(GO:0006868) |
1.7 | 5.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.7 | 8.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.7 | 13.2 | GO:0007343 | egg activation(GO:0007343) |
1.6 | 4.9 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.6 | 9.6 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
1.6 | 8.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.6 | 8.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.6 | 1.6 | GO:0061724 | lipophagy(GO:0061724) |
1.5 | 16.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
1.5 | 9.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.5 | 4.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.5 | 6.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.5 | 4.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.5 | 13.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
1.5 | 4.4 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
1.5 | 1.5 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.5 | 4.4 | GO:0040031 | snRNA modification(GO:0040031) |
1.4 | 5.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.4 | 4.3 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
1.4 | 4.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
1.4 | 4.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.4 | 2.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.4 | 2.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.4 | 8.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.4 | 4.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.4 | 4.2 | GO:1903232 | melanosome assembly(GO:1903232) |
1.4 | 5.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
1.4 | 1.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
1.4 | 8.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.4 | 5.4 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.4 | 4.1 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.3 | 4.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.3 | 8.0 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.3 | 6.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.3 | 4.0 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
1.3 | 4.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.3 | 7.9 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
1.3 | 3.9 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
1.3 | 3.9 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
1.3 | 5.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.3 | 1.3 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.3 | 9.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.3 | 3.8 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.3 | 14.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
1.3 | 12.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.2 | 3.7 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.2 | 3.6 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.2 | 1.2 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
1.2 | 6.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.2 | 7.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.2 | 4.8 | GO:0006848 | pyruvate transport(GO:0006848) |
1.2 | 3.6 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.2 | 2.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.2 | 2.3 | GO:0032898 | neurotrophin production(GO:0032898) |
1.2 | 4.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.2 | 4.6 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.2 | 4.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
1.1 | 4.6 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
1.1 | 2.3 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
1.1 | 6.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.1 | 4.5 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
1.1 | 10.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
1.1 | 10.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.1 | 2.2 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
1.1 | 20.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.1 | 3.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.1 | 5.6 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
1.1 | 21.9 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.1 | 2.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.1 | 10.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
1.1 | 1.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.1 | 3.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.1 | 2.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
1.1 | 3.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.1 | 2.2 | GO:0050955 | thermoception(GO:0050955) |
1.1 | 6.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.1 | 5.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.1 | 6.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
1.1 | 11.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.1 | 2.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.1 | 2.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.0 | 6.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.0 | 4.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.0 | 3.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.0 | 6.1 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
1.0 | 5.0 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
1.0 | 3.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
1.0 | 3.0 | GO:0009629 | response to gravity(GO:0009629) |
1.0 | 5.0 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
1.0 | 6.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.0 | 8.9 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
1.0 | 2.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.0 | 3.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.0 | 4.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.0 | 9.8 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
1.0 | 1.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.0 | 7.8 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
1.0 | 2.9 | GO:0000087 | mitotic M phase(GO:0000087) |
1.0 | 2.9 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.0 | 4.8 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
1.0 | 2.9 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.9 | 2.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.9 | 1.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.9 | 1.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.9 | 7.5 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.9 | 3.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.9 | 2.8 | GO:0007525 | somatic muscle development(GO:0007525) |
0.9 | 0.9 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.9 | 1.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.9 | 3.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.9 | 1.8 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.9 | 2.7 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.9 | 0.9 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.9 | 2.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.9 | 7.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.9 | 7.0 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.9 | 7.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.9 | 4.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.9 | 1.7 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.9 | 0.9 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.9 | 2.6 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.9 | 2.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.9 | 5.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.9 | 0.9 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.9 | 11.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.8 | 5.1 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.8 | 0.8 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.8 | 2.5 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.8 | 19.4 | GO:0048821 | erythrocyte development(GO:0048821) |
0.8 | 5.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.8 | 14.3 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.8 | 3.4 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.8 | 0.8 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.8 | 1.7 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.8 | 4.1 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.8 | 2.5 | GO:0090135 | actin filament branching(GO:0090135) |
0.8 | 4.9 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.8 | 17.2 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.8 | 3.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.8 | 6.5 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.8 | 2.5 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.8 | 2.5 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.8 | 2.4 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.8 | 4.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.8 | 3.2 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.8 | 2.4 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.8 | 12.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.8 | 1.6 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.8 | 1.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.8 | 4.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.8 | 0.8 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.8 | 0.8 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.8 | 4.7 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.8 | 3.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.8 | 2.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.8 | 0.8 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.8 | 3.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.8 | 1.6 | GO:0072179 | nephric duct formation(GO:0072179) |
0.8 | 13.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.8 | 1.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.8 | 3.1 | GO:0060066 | oviduct development(GO:0060066) |
0.8 | 11.5 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.8 | 2.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.8 | 0.8 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.8 | 1.5 | GO:0050904 | diapedesis(GO:0050904) |
0.8 | 3.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.8 | 2.3 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.8 | 2.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.8 | 2.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.8 | 5.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.7 | 3.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.7 | 1.5 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.7 | 1.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.7 | 0.7 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.7 | 5.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.7 | 2.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.7 | 1.5 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.7 | 0.7 | GO:0000050 | urea cycle(GO:0000050) |
0.7 | 2.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.7 | 1.5 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.7 | 2.9 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.7 | 2.2 | GO:0060594 | mammary gland specification(GO:0060594) |
0.7 | 1.5 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.7 | 1.4 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.7 | 2.2 | GO:0035799 | ureter maturation(GO:0035799) |
0.7 | 2.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.7 | 3.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.7 | 1.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.7 | 1.4 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.7 | 0.7 | GO:0015817 | histidine transport(GO:0015817) |
0.7 | 2.9 | GO:0006573 | valine metabolic process(GO:0006573) |
0.7 | 2.8 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.7 | 4.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.7 | 1.4 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.7 | 4.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.7 | 2.1 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 | 6.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.7 | 1.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.7 | 4.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.7 | 4.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.7 | 2.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.7 | 0.7 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.7 | 2.1 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
0.7 | 2.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.7 | 2.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.7 | 2.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.7 | 0.7 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.7 | 4.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.7 | 4.7 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.7 | 1.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.7 | 2.7 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.7 | 7.3 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.7 | 2.7 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.7 | 11.9 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.7 | 2.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.7 | 5.3 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.7 | 13.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.7 | 2.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.7 | 0.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.6 | 2.6 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.6 | 2.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.6 | 2.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.6 | 2.6 | GO:0009597 | detection of virus(GO:0009597) |
0.6 | 2.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 2.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.6 | 1.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 1.3 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.6 | 3.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.6 | 3.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.6 | 5.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.6 | 3.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.6 | 3.7 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.6 | 3.1 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.6 | 0.6 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.6 | 2.4 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.6 | 0.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.6 | 4.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.6 | 1.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.6 | 1.8 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.6 | 0.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.6 | 1.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.6 | 2.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.6 | 1.8 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.6 | 1.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.6 | 0.6 | GO:0097503 | sialylation(GO:0097503) |
0.6 | 5.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.6 | 0.6 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.6 | 8.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.6 | 1.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.6 | 3.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.6 | 2.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.6 | 1.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.6 | 3.5 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.6 | 3.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.6 | 1.7 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.6 | 0.6 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.6 | 5.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.6 | 2.9 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.6 | 5.2 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.6 | 3.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.6 | 1.7 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.6 | 1.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.6 | 0.6 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.6 | 0.6 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.6 | 3.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.6 | 10.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.6 | 5.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.6 | 5.1 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.6 | 10.7 | GO:0014823 | response to activity(GO:0014823) |
0.6 | 0.6 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.6 | 1.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.6 | 5.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.6 | 4.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.6 | 10.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.6 | 0.6 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.6 | 0.6 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.6 | 1.7 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.6 | 1.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.6 | 6.1 | GO:0070166 | enamel mineralization(GO:0070166) |
0.6 | 0.6 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.6 | 22.1 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.6 | 2.2 | GO:0009838 | abscission(GO:0009838) |
0.6 | 3.9 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.5 | 2.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.5 | 2.2 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.5 | 1.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.5 | 1.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.5 | 18.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.5 | 3.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.5 | 14.6 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.5 | 3.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.5 | 3.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.5 | 1.6 | GO:0006116 | NADH oxidation(GO:0006116) |
0.5 | 1.6 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.5 | 2.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.5 | 2.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.5 | 0.5 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.5 | 1.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.5 | 1.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.5 | 4.2 | GO:1904851 | positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.5 | 0.5 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.5 | 0.5 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.5 | 1.0 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.5 | 4.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.5 | 18.2 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.5 | 3.6 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.5 | 1.6 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.5 | 6.2 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.5 | 1.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.5 | 1.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.5 | 1.5 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.5 | 1.0 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.5 | 1.5 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.5 | 0.5 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.5 | 0.5 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.5 | 2.5 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.5 | 1.5 | GO:0036233 | glycine import(GO:0036233) |
0.5 | 2.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 4.5 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.5 | 1.5 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.5 | 1.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.5 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.5 | 5.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.5 | 1.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.5 | 0.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.5 | 0.5 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.5 | 2.9 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.5 | 4.4 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.5 | 1.5 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.5 | 10.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.5 | 9.7 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.5 | 1.4 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.5 | 4.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.5 | 1.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 1.9 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.5 | 0.9 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.5 | 9.0 | GO:0019835 | cytolysis(GO:0019835) |
0.5 | 0.5 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.5 | 1.9 | GO:0015705 | iodide transport(GO:0015705) |
0.5 | 0.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.5 | 0.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.5 | 1.9 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.5 | 0.9 | GO:0048254 | snoRNA localization(GO:0048254) |
0.5 | 0.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 1.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.5 | 0.5 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.5 | 13.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.5 | 0.5 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.5 | 0.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.5 | 1.8 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.5 | 2.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.5 | 2.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.5 | 1.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 1.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.4 | 1.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.4 | 5.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 16.9 | GO:0001889 | liver development(GO:0001889) |
0.4 | 1.8 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.4 | 0.9 | GO:0042161 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.4 | 0.9 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 0.9 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.4 | 0.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 3.5 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.4 | 0.4 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.4 | 0.9 | GO:0061183 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
0.4 | 3.5 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.4 | 1.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.4 | 0.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.4 | 1.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.4 | 2.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.4 | 0.9 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.4 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 2.6 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.4 | 12.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.4 | 0.9 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
0.4 | 4.7 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.4 | 3.4 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.4 | 0.9 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.4 | 1.3 | GO:0090148 | membrane fission(GO:0090148) |
0.4 | 1.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.4 | 1.7 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.4 | 2.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.4 | 3.8 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.4 | 9.3 | GO:0042168 | heme metabolic process(GO:0042168) |
0.4 | 0.8 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
0.4 | 12.2 | GO:0007031 | peroxisome organization(GO:0007031) |
0.4 | 1.7 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 2.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.4 | 0.8 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.4 | 5.0 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.4 | 1.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.4 | 1.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 1.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.4 | 0.8 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.4 | 1.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 0.8 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.4 | 1.6 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.4 | 0.4 | GO:1901983 | regulation of protein acetylation(GO:1901983) |
0.4 | 2.0 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.4 | 2.9 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.4 | 1.6 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.4 | 1.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.4 | 1.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 4.5 | GO:0031100 | organ regeneration(GO:0031100) |
0.4 | 4.1 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 1.6 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 1.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.4 | 2.4 | GO:0032373 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.4 | 8.5 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.4 | 1.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.4 | 8.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.4 | 1.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.4 | 1.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 3.6 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 1.6 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.4 | 0.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.4 | 0.4 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 5.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.4 | 0.4 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.4 | 0.8 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.4 | 1.6 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.4 | 1.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.4 | 2.7 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.4 | 1.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.4 | 3.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.4 | 3.9 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.4 | 0.4 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.4 | 1.2 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.4 | 3.1 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.4 | 2.3 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.4 | 1.2 | GO:0042701 | progesterone secretion(GO:0042701) |
0.4 | 1.2 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.4 | 1.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.4 | 14.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.4 | 3.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.4 | 1.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.4 | 1.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.4 | 0.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.4 | 1.5 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.4 | 3.8 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.4 | 0.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.4 | 0.8 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) negative regulation of mast cell apoptotic process(GO:0033026) |
0.4 | 0.8 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.4 | 4.5 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.4 | 0.7 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 1.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 1.1 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 0.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.4 | 3.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.4 | 3.0 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.4 | 1.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 0.7 | GO:0030576 | Cajal body organization(GO:0030576) |
0.4 | 5.1 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.4 | 1.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 2.2 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.4 | 0.4 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.4 | 0.4 | GO:0038107 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.4 | 2.5 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.4 | 6.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.4 | 2.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.4 | 1.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.4 | 1.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 2.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.4 | 1.4 | GO:0070723 | response to cholesterol(GO:0070723) |
0.4 | 0.7 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.4 | 1.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.4 | 3.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.4 | 0.7 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.4 | 1.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.4 | 1.8 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.4 | 4.9 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.4 | 1.1 | GO:0060931 | cardiac pacemaker cell differentiation(GO:0060920) sinoatrial node cell differentiation(GO:0060921) cardiac pacemaker cell development(GO:0060926) sinoatrial node cell development(GO:0060931) |
0.4 | 0.7 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.3 | 1.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.3 | 3.1 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.3 | 0.3 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.3 | 3.1 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.3 | 1.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 1.4 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.3 | 4.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 1.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 1.7 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 1.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.3 | 0.3 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.3 | 1.0 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.3 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.3 | 0.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.3 | 1.0 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.3 | 0.3 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.3 | 1.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 1.0 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 0.7 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.3 | 3.3 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.3 | 1.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.3 | 0.7 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.3 | 0.7 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 2.3 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 3.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.3 | 0.7 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.3 | 1.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 1.0 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 6.6 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 0.7 | GO:1902966 | protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.3 | 0.3 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.3 | 2.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.3 | 2.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 0.7 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.3 | 2.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 0.3 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.3 | 1.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 1.3 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.3 | 2.6 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.3 | 1.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.3 | 0.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 0.3 | GO:0009220 | pyrimidine ribonucleotide biosynthetic process(GO:0009220) pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
0.3 | 1.6 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.3 | 0.3 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.3 | 0.6 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.3 | 0.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 6.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.3 | 3.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.3 | 0.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 1.6 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 2.2 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.3 | 5.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.3 | 7.2 | GO:0006956 | complement activation(GO:0006956) |
0.3 | 4.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.3 | 1.6 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 1.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.3 | 0.6 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.3 | 1.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.3 | 0.9 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.3 | 4.7 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.3 | 2.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.3 | 2.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 3.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 0.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 1.2 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.3 | 0.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.3 | 3.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 0.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.3 | 1.2 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.3 | 0.6 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 1.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.3 | 3.6 | GO:0001706 | endoderm formation(GO:0001706) |
0.3 | 6.7 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.3 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 13.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 0.3 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.3 | 0.9 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.3 | 4.5 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.3 | 3.6 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.3 | 0.9 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 1.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 1.8 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.3 | 0.9 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.3 | 0.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 1.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.3 | 4.5 | GO:0009303 | rRNA transcription(GO:0009303) |
0.3 | 1.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.3 | 0.6 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.3 | 2.7 | GO:0042407 | cristae formation(GO:0042407) |
0.3 | 0.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.3 | 0.9 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 1.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 2.0 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.3 | 2.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 0.3 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.3 | 0.6 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.3 | 3.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.6 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.3 | 0.6 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 0.3 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.3 | 0.6 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.3 | 2.0 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 0.3 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.3 | 1.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 0.9 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.3 | 4.8 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.3 | 0.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 2.0 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 0.3 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.3 | 0.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.3 | 3.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.3 | 0.6 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.3 | 0.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.3 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.3 | 4.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 2.8 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 1.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.3 | 0.3 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.3 | 0.6 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.3 | 1.4 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.3 | 1.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 2.2 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.3 | 0.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.3 | 10.7 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.3 | 1.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 1.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.3 | 1.4 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.3 | 0.5 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.3 | 2.7 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.3 | 0.8 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.3 | 2.7 | GO:1904353 | regulation of telomere capping(GO:1904353) |
0.3 | 6.7 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.3 | 0.3 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 0.5 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.3 | 0.5 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 2.9 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.3 | 1.3 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.3 | 0.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 5.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 1.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 0.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.8 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.3 | 0.8 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.3 | 0.8 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.3 | 0.3 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.3 | 0.3 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.3 | 6.5 | GO:1901998 | toxin transport(GO:1901998) |
0.3 | 10.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.3 | 0.3 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.3 | 0.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 0.5 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.3 | 0.3 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.3 | 0.5 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.3 | 0.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.3 | 9.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 0.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 3.1 | GO:0051180 | vitamin transport(GO:0051180) |
0.3 | 0.5 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.3 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 2.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 0.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 1.0 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.3 | 1.8 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.3 | 0.8 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.3 | 1.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 1.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 2.3 | GO:0070633 | transepithelial transport(GO:0070633) |
0.3 | 1.8 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.3 | 0.8 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.3 | 1.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.3 | 0.8 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.3 | 0.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.3 | 3.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 0.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 2.0 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.2 | 1.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 0.5 | GO:0006382 | adenosine to inosine editing(GO:0006382) base conversion or substitution editing(GO:0016553) |
0.2 | 0.2 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.2 | 0.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.7 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 3.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 1.0 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 1.5 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 3.1 | GO:0035904 | aorta development(GO:0035904) |
0.2 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.2 | 0.7 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.2 | 0.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 1.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 3.6 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.2 | 3.8 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.2 | 2.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 0.7 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.2 | 0.2 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.2 | 0.2 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.2 | 0.5 | GO:0098856 | intestinal lipid absorption(GO:0098856) |
0.2 | 0.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 3.3 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 1.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 1.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.2 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.2 | 0.9 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.2 | 0.7 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 14.0 | GO:0006413 | translational initiation(GO:0006413) |
0.2 | 0.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 0.2 | GO:0090671 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.2 | 0.2 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.2 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 1.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.2 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.2 | 0.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 1.6 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 0.5 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 0.2 | GO:0052433 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
0.2 | 0.9 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.2 | 1.3 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.2 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
0.2 | 2.5 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 0.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 4.7 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.2 | 1.1 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.2 | 1.1 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 0.4 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 0.2 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.2 | 0.4 | GO:0045979 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.2 | 0.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 4.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.7 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.3 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.2 | 0.2 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.2 | 1.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 1.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 0.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.4 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 9.1 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.2 | 1.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.6 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.2 | 0.4 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.6 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.2 | 0.4 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.2 | 0.2 | GO:0034311 | diol metabolic process(GO:0034311) |
0.2 | 1.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 1.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.4 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 0.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 1.3 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.2 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 1.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 0.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 1.5 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 1.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.4 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.2 | 0.8 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.2 | 3.5 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.2 | 6.0 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 1.7 | GO:0042048 | olfactory behavior(GO:0042048) |
0.2 | 0.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.2 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.2 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 2.9 | GO:0051923 | sulfation(GO:0051923) |
0.2 | 0.6 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.2 | 1.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 2.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.2 | GO:2000399 | negative regulation of thymocyte aggregation(GO:2000399) |
0.2 | 1.4 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.2 | 0.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.8 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 0.8 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.4 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 1.2 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.2 | 1.8 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 1.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 1.6 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.2 | 2.2 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.2 | 0.2 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 1.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 0.2 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.6 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 1.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 0.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 3.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.2 | 0.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 1.2 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 0.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 1.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.2 | 0.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.2 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.2 | 2.1 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 0.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.2 | 0.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 4.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 1.9 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.2 | 1.9 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.4 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.2 | 0.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 1.7 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.2 | 3.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 0.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.2 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.2 | 0.8 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 0.6 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.2 | 0.2 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.2 | 16.6 | GO:0006869 | lipid transport(GO:0006869) |
0.2 | 0.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 1.5 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 1.1 | GO:0045953 | negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.2 | 0.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 0.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.2 | 1.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 6.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.4 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.2 | 1.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 0.6 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 23.7 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.2 | 0.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.5 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.2 | 1.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 2.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 1.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.2 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.2 | 1.6 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 1.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.2 | 2.8 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.2 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.2 | 0.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 2.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 1.4 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.2 | 1.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.7 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.2 | 0.4 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.2 | 1.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.2 | 1.2 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.2 | 0.2 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.2 | 1.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 0.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.2 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.2 | 0.3 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.2 | 0.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 1.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 4.0 | GO:0032418 | lysosome localization(GO:0032418) |
0.2 | 7.6 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.2 | 0.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.2 | 0.7 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.2 | 1.9 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.2 | 1.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 1.2 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.2 | 1.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.7 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.2 | 0.3 | GO:0043301 | negative regulation of leukocyte degranulation(GO:0043301) |
0.2 | 0.7 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.7 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.2 | 0.5 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.2 | 0.8 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 0.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.8 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 1.7 | GO:0031050 | dsRNA fragmentation(GO:0031050) production of miRNAs involved in gene silencing by miRNA(GO:0035196) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.2 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.2 | GO:0097286 | iron ion import(GO:0097286) |
0.2 | 0.8 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.2 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 2.5 | GO:0033198 | response to ATP(GO:0033198) |
0.2 | 0.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 4.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.2 | 0.2 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.2 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.3 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 0.8 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.2 | 2.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.8 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.2 | 0.3 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.2 | 0.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.2 | 1.0 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.2 | 0.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 2.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 0.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.5 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 0.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 1.4 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.2 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.2 | GO:0060281 | regulation of oocyte development(GO:0060281) |
0.2 | 1.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.2 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 0.3 | GO:0042033 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) positive regulation of chemokine biosynthetic process(GO:0045080) |
0.2 | 0.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.2 | 1.1 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 0.3 | GO:0046102 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.2 | 0.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 2.4 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.2 | 0.3 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 0.3 | GO:0052312 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.2 | 0.6 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 1.9 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 0.5 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.2 | 0.5 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 0.6 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 0.8 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 2.0 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.2 | 2.0 | GO:0017145 | stem cell division(GO:0017145) |
0.2 | 0.6 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 1.6 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.4 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 1.8 | GO:0046854 | lipid phosphorylation(GO:0046834) phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.1 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.1 | GO:0002118 | aggressive behavior(GO:0002118) |
0.1 | 0.3 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 2.2 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 1.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 2.2 | GO:0044743 | intracellular protein transmembrane import(GO:0044743) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 2.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 1.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.3 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 1.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.7 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 4.2 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.1 | 0.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.4 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 15.4 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.1 | 1.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.3 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.1 | 10.6 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.7 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.3 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 2.1 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.1 | 0.3 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.1 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.1 | 0.3 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.1 | 0.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 2.1 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 1.2 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.7 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 1.6 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.1 | 0.1 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.5 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
0.1 | 0.6 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.1 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 1.9 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.3 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.1 | GO:1900221 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) negative regulation of lipoprotein particle clearance(GO:0010985) regulation of beta-amyloid clearance(GO:1900221) negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 1.5 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.2 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 1.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 3.9 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.9 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.6 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 3.5 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.1 | 0.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.5 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 1.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.6 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 1.9 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.2 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 2.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.4 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 0.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 1.5 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.2 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.6 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.5 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 1.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.1 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.1 | 0.6 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.2 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.2 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 5.0 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.1 | 0.4 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.4 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.3 | GO:0090329 | regulation of DNA-dependent DNA replication(GO:0090329) |
0.1 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.2 | GO:0071312 | cellular response to alkaloid(GO:0071312) |
0.1 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 1.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.6 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 2.4 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.1 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.1 | 0.8 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.1 | 0.8 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.9 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 2.4 | GO:0019079 | viral genome replication(GO:0019079) |
0.1 | 0.5 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 1.7 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.7 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 1.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.7 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.1 | 0.4 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.6 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 0.1 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 2.1 | GO:0031929 | TOR signaling(GO:0031929) |
0.1 | 2.8 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.9 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.2 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 2.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.2 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 0.2 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.2 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) deoxyribose phosphate catabolic process(GO:0046386) |
0.1 | 0.3 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.7 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.5 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.2 | GO:1903312 | negative regulation of mRNA metabolic process(GO:1903312) |
0.1 | 0.2 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.1 | 0.2 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 2.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.5 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.2 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.1 | 0.5 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.1 | 0.2 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 2.6 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.3 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.1 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 0.1 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.1 | 0.3 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 1.8 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 1.7 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.1 | 0.2 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 0.1 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.1 | 0.1 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.1 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 1.4 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.4 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.2 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 19.1 | GO:0006396 | RNA processing(GO:0006396) |
0.1 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.6 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.1 | 0.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.5 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 0.1 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.1 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.1 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.1 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.1 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.1 | 0.1 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.3 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.3 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.3 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.1 | 0.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.2 | GO:0044003 | modification by symbiont of host morphology or physiology(GO:0044003) |
0.1 | 2.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.3 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 3.0 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.1 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.1 | 0.3 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.1 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.7 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.1 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.3 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.8 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.4 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.1 | 0.1 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.1 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.1 | 0.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.3 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 0.1 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.1 | 0.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.1 | 0.1 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.3 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.2 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.2 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.1 | 0.3 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.4 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) |
0.1 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.3 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.1 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 1.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.4 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 0.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.2 | GO:0030800 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) negative regulation of cAMP metabolic process(GO:0030815) negative regulation of purine nucleotide metabolic process(GO:1900543) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.4 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.1 | 0.1 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.1 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.1 | 0.3 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.9 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.1 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.3 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.1 | 0.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.7 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 1.6 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.1 | 0.6 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.1 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.1 | GO:0055026 | negative regulation of cardiac muscle tissue development(GO:0055026) |
0.1 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.2 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.1 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 1.1 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.1 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 1.2 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.2 | GO:0032885 | regulation of polysaccharide biosynthetic process(GO:0032885) |
0.1 | 0.5 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 0.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.1 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.1 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 0.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.9 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.1 | 0.1 | GO:0071634 | transforming growth factor beta production(GO:0071604) regulation of transforming growth factor beta production(GO:0071634) |
0.1 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.4 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.3 | GO:0070555 | response to interleukin-1(GO:0070555) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.8 | GO:1905039 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.0 | 1.0 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.0 | 0.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.3 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.0 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.0 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.0 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.0 | 0.1 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.0 | 0.0 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.5 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.3 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.0 | 0.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.0 | 0.0 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.0 | 0.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.3 | GO:0001952 | regulation of cell-matrix adhesion(GO:0001952) |
0.0 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.0 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.0 | 0.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.2 | GO:0098762 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.5 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.0 | 0.1 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.1 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.0 | 0.3 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.2 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) |
0.0 | 0.2 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.0 | 0.2 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.0 | 0.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.5 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.1 | GO:0043299 | leukocyte degranulation(GO:0043299) |
0.0 | 0.4 | GO:0002526 | acute inflammatory response(GO:0002526) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.0 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.0 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.0 | 0.0 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.0 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 0.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.2 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.0 | 0.0 | GO:0015809 | arginine transport(GO:0015809) |
0.0 | 0.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.0 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.6 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) nucleotide phosphorylation(GO:0046939) |
0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.1 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
0.0 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.0 | 0.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.0 | 0.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.1 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.2 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.0 | 0.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.2 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.0 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.0 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.0 | 0.2 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.0 | 0.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.1 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.0 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.2 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 | 0.0 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.0 | 0.1 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.6 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.2 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.1 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.2 | GO:0043627 | response to estrogen(GO:0043627) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.4 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.0 | 0.0 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.0 | GO:0019230 | proprioception(GO:0019230) |
0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.4 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.0 | 2.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.4 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.1 | GO:0051647 | nucleus localization(GO:0051647) |
0.0 | 0.3 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 0.1 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 0.0 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.0 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.0 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.1 | GO:0055021 | regulation of cardiac muscle tissue growth(GO:0055021) |
0.0 | 0.1 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.0 | 0.0 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.0 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.0 | 0.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.3 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 1.8 | GO:0032259 | methylation(GO:0032259) |
0.0 | 0.0 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.1 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
0.0 | 0.1 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.0 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.0 | 0.0 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.1 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.0 | 0.2 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.0 | GO:0019755 | one-carbon compound transport(GO:0019755) |
0.0 | 0.0 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.0 | 0.0 | GO:0023058 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.0 | 0.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.0 | GO:0050779 | RNA destabilization(GO:0050779) |
0.0 | 0.0 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.0 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.1 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.0 | 0.1 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.0 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.0 | 0.0 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.2 | GO:0090277 | positive regulation of peptide hormone secretion(GO:0090277) |
0.0 | 0.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.2 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.0 | 0.0 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.1 | GO:0007584 | response to nutrient(GO:0007584) |
0.0 | 0.7 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.1 | GO:0031279 | regulation of cyclase activity(GO:0031279) |
0.0 | 0.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.1 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 0.3 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.0 | GO:0003143 | embryonic heart tube morphogenesis(GO:0003143) |
0.0 | 0.0 | GO:0060405 | regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
0.0 | 0.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.0 | 4.2 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.0 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.0 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.0 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.0 | 0.0 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.0 | 0.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.0 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.0 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.0 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.0 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0002275 | myeloid cell activation involved in immune response(GO:0002275) |
0.0 | 0.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.0 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.0 | 0.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.1 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.0 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.0 | 0.0 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.0 | 0.0 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.0 | 0.0 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.2 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.0 | 0.0 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.1 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.0 | GO:2000142 | regulation of DNA-templated transcription, initiation(GO:2000142) |
0.0 | 0.0 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.0 | 0.1 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.0 | 0.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.0 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.0 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.0 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.0 | 0.0 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 0.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0010662 | regulation of striated muscle cell apoptotic process(GO:0010662) |
0.0 | 0.0 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0044042 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.0 | 0.0 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.0 | GO:0051304 | chromosome separation(GO:0051304) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 23.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
3.9 | 11.7 | GO:0032010 | phagolysosome(GO:0032010) |
3.5 | 20.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
3.3 | 9.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
3.2 | 16.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
3.2 | 9.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
2.8 | 14.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.5 | 12.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
2.2 | 2.2 | GO:0097422 | tubular endosome(GO:0097422) |
2.2 | 21.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
2.1 | 6.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
2.1 | 10.4 | GO:0005579 | membrane attack complex(GO:0005579) |
1.8 | 5.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.6 | 8.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.6 | 9.6 | GO:0045180 | basal cortex(GO:0045180) |
1.5 | 1.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.4 | 5.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.4 | 6.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.4 | 4.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.4 | 16.3 | GO:0071564 | npBAF complex(GO:0071564) |
1.3 | 6.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.3 | 1.3 | GO:0090543 | Flemming body(GO:0090543) |
1.3 | 10.2 | GO:0036157 | outer dynein arm(GO:0036157) |
1.3 | 11.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.2 | 5.0 | GO:0030478 | actin cap(GO:0030478) |
1.2 | 6.0 | GO:0030870 | Mre11 complex(GO:0030870) |
1.2 | 7.2 | GO:0031983 | vesicle lumen(GO:0031983) |
1.2 | 8.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.2 | 5.8 | GO:0005638 | lamin filament(GO:0005638) |
1.1 | 13.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
1.1 | 4.5 | GO:0042827 | platelet dense granule(GO:0042827) |
1.1 | 12.4 | GO:0070852 | cell body fiber(GO:0070852) |
1.1 | 8.9 | GO:0030056 | hemidesmosome(GO:0030056) |
1.1 | 3.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.1 | 4.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.0 | 29.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.0 | 8.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
1.0 | 6.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.0 | 3.1 | GO:0005914 | spot adherens junction(GO:0005914) |
1.0 | 3.1 | GO:0070552 | BRISC complex(GO:0070552) |
1.0 | 1.0 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
1.0 | 4.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.0 | 7.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.0 | 6.0 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.0 | 1.0 | GO:0030315 | T-tubule(GO:0030315) |
1.0 | 10.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.9 | 0.9 | GO:0071797 | LUBAC complex(GO:0071797) |
0.9 | 12.7 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.9 | 9.8 | GO:0032797 | SMN complex(GO:0032797) |
0.9 | 3.6 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.9 | 3.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.9 | 2.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.9 | 3.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.9 | 17.5 | GO:0005922 | connexon complex(GO:0005922) |
0.9 | 1.7 | GO:0042555 | MCM complex(GO:0042555) |
0.9 | 3.5 | GO:0030891 | VCB complex(GO:0030891) |
0.9 | 7.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.8 | 12.7 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.8 | 9.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.8 | 3.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.8 | 12.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.8 | 2.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 2.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.8 | 3.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.8 | 75.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.8 | 4.6 | GO:0071986 | Ragulator complex(GO:0071986) |
0.8 | 5.3 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.8 | 3.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.7 | 6.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.7 | 6.0 | GO:0045179 | apical cortex(GO:0045179) |
0.7 | 2.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.7 | 13.8 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.7 | 0.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.7 | 1.4 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.7 | 5.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.7 | 2.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.7 | 0.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.7 | 11.0 | GO:0010369 | chromocenter(GO:0010369) |
0.7 | 7.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.7 | 2.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.7 | 2.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.7 | 4.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.7 | 2.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.7 | 9.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.7 | 5.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.7 | 0.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.6 | 3.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.6 | 23.7 | GO:0045095 | keratin filament(GO:0045095) |
0.6 | 3.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.6 | 1.9 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.6 | 10.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.6 | 3.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.6 | 4.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.6 | 2.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.6 | 1.8 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.6 | 2.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.6 | 1.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.6 | 10.5 | GO:0030904 | retromer complex(GO:0030904) |
0.6 | 12.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.6 | 0.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.6 | 15.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.6 | 8.1 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.6 | 1.2 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.6 | 2.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.6 | 2.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.6 | 3.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.6 | 1.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.6 | 15.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.6 | 1.7 | GO:0071010 | prespliceosome(GO:0071010) |
0.6 | 0.6 | GO:0042627 | chylomicron(GO:0042627) |
0.6 | 5.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.6 | 10.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.6 | 8.9 | GO:0030286 | dynein complex(GO:0030286) |
0.5 | 42.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.5 | 2.7 | GO:0000346 | transcription export complex(GO:0000346) |
0.5 | 65.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.5 | 1.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.5 | 2.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 1.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.5 | 1.5 | GO:0000811 | GINS complex(GO:0000811) |
0.5 | 26.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.5 | 2.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 5.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 15.7 | GO:0072686 | mitotic spindle(GO:0072686) |
0.5 | 9.6 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.5 | 3.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.5 | 2.0 | GO:0035339 | SPOTS complex(GO:0035339) |
0.5 | 2.5 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.5 | 5.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.5 | 5.9 | GO:0000974 | Prp19 complex(GO:0000974) |
0.5 | 3.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.5 | 4.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.5 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.5 | 7.8 | GO:0000145 | exocyst(GO:0000145) |
0.5 | 1.9 | GO:0016589 | NURF complex(GO:0016589) |
0.5 | 1.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.5 | 2.9 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.5 | 3.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 1.4 | GO:0030689 | Noc complex(GO:0030689) |
0.5 | 0.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.5 | 2.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.5 | 1.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.5 | 0.5 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.5 | 4.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.5 | 3.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 9.6 | GO:0000791 | euchromatin(GO:0000791) |
0.5 | 3.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 3.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.4 | 1.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 2.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.4 | 2.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.4 | 1.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 25.2 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.4 | 1.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.4 | 9.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.4 | 1.3 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 3.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 23.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 1.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.4 | 14.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.4 | 4.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.4 | 3.7 | GO:0070938 | contractile ring(GO:0070938) |
0.4 | 3.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.4 | 2.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 0.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 1.2 | GO:0071014 | U2-type post-mRNA release spliceosomal complex(GO:0071008) post-mRNA release spliceosomal complex(GO:0071014) |
0.4 | 0.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.4 | 1.9 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.4 | 1.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.4 | 5.0 | GO:0031082 | BLOC complex(GO:0031082) |
0.4 | 0.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 0.8 | GO:0044393 | microspike(GO:0044393) |
0.4 | 1.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 4.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 1.5 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 1.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 1.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 2.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.4 | 5.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 1.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 15.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.4 | 3.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.4 | 7.3 | GO:0000786 | nucleosome(GO:0000786) |
0.4 | 0.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.4 | 2.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 1.1 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.4 | 14.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.4 | 4.7 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 2.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 1.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 1.0 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 1.0 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 2.1 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 1.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 2.7 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.3 | 3.7 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 8.8 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 8.4 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.3 | 2.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 12.6 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.3 | 1.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.3 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 4.9 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 1.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 0.6 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 2.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 2.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 2.5 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 1.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.3 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 1.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 0.9 | GO:0097342 | ripoptosome(GO:0097342) |
0.3 | 0.3 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.3 | 1.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 5.8 | GO:0005839 | proteasome core complex(GO:0005839) |
0.3 | 1.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 0.9 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 1.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.3 | 8.7 | GO:0030027 | lamellipodium(GO:0030027) |
0.3 | 0.9 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 0.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.3 | 3.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.3 | 3.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 0.6 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 1.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 3.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 3.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 1.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 18.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.3 | 0.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 17.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 2.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 2.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 2.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.3 | 8.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.3 | 0.3 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.3 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 1.3 | GO:0045252 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 0.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 6.5 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 0.3 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 2.3 | GO:0045178 | basal part of cell(GO:0045178) |
0.3 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 1.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 0.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 1.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 11.8 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 25.6 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 0.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 3.9 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 7.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 6.3 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.2 | 2.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 76.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 3.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.7 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 1.0 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 1.7 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 2.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 2.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 6.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 1.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 1.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 2.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 4.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 2.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 9.2 | GO:0005903 | brush border(GO:0005903) |
0.2 | 1.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 1.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 0.2 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.2 | 1.9 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 1.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 6.2 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 1.3 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 2.7 | GO:0043034 | costamere(GO:0043034) |
0.2 | 2.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 54.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.2 | 1.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 1.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 19.0 | GO:0016604 | nuclear body(GO:0016604) |
0.2 | 5.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 1.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 0.6 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 2.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 2.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 5.2 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 51.3 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 5.1 | GO:0000792 | heterochromatin(GO:0000792) |
0.2 | 0.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.5 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 1.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 1.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 2.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.2 | 7.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 3.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 1.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 6.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 2.8 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 10.2 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 1.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 0.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 0.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 0.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.3 | GO:0070187 | telosome(GO:0070187) |
0.2 | 2.7 | GO:0030684 | preribosome(GO:0030684) |
0.2 | 0.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 12.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 2.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 145.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 1.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 4.9 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.2 | 0.2 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 2.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 2.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.2 | 1.0 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 0.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 1.1 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.9 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.2 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.5 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 1.2 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 15.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 1.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 3.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 3.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 1.6 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 100.7 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 10.0 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.8 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 29.5 | GO:0005773 | vacuole(GO:0005773) |
0.1 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.4 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 4.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 4.0 | GO:0012506 | vesicle membrane(GO:0012506) |
0.1 | 0.1 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.1 | 2.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 8.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 7.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 2.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 6.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 2.6 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 5.4 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 7.4 | GO:0031410 | cytoplasmic vesicle(GO:0031410) |
0.1 | 0.6 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.7 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 11.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 3.7 | GO:0030141 | secretory granule(GO:0030141) |
0.1 | 135.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 1.2 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 2.6 | GO:0005814 | centriole(GO:0005814) |
0.1 | 28.4 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.2 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 1.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.7 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) catalytic step 1 spliceosome(GO:0071012) |
0.1 | 2.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.6 | GO:0031430 | M band(GO:0031430) |
0.1 | 2.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.5 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 1.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.1 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.3 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 0.5 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 59.4 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 49.8 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 2.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 1.2 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.2 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 57.0 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.2 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.2 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 3.8 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.1 | 0.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.5 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.3 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 50.4 | GO:0012505 | endomembrane system(GO:0012505) |
0.1 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.9 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 1.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 4.8 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 3.8 | GO:0005929 | cilium(GO:0005929) |
0.1 | 0.2 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.4 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.3 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.6 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 0.3 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 82.7 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 0.0 | GO:0031982 | vesicle(GO:0031982) |
0.0 | 3.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.0 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.2 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.0 | 0.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 8.0 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.0 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 0.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.0 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 20.8 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 0.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.0 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.6 | 19.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
5.3 | 16.0 | GO:0019862 | IgA binding(GO:0019862) |
4.8 | 14.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
4.0 | 12.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
3.8 | 11.5 | GO:2001069 | glycogen binding(GO:2001069) |
3.6 | 10.9 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
3.4 | 13.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
3.3 | 10.0 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
3.3 | 10.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
3.3 | 13.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
3.2 | 12.9 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
3.2 | 22.3 | GO:0046790 | virion binding(GO:0046790) |
3.2 | 9.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
3.1 | 12.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
3.1 | 9.2 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
3.0 | 12.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
2.8 | 8.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
2.6 | 7.7 | GO:0050692 | DBD domain binding(GO:0050692) |
2.5 | 10.1 | GO:0038100 | nodal binding(GO:0038100) |
2.5 | 19.7 | GO:0034046 | poly(G) binding(GO:0034046) |
2.2 | 6.7 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
2.2 | 6.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
2.1 | 8.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
2.1 | 6.3 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.1 | 6.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
2.0 | 8.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
2.0 | 8.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
2.0 | 15.9 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
1.9 | 11.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.9 | 7.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.8 | 9.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.8 | 30.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.7 | 11.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.7 | 5.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.6 | 16.1 | GO:0001846 | opsonin binding(GO:0001846) |
1.6 | 8.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.6 | 9.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.5 | 4.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.5 | 6.1 | GO:0035276 | ethanol binding(GO:0035276) |
1.5 | 6.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.5 | 4.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.5 | 7.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.4 | 14.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.4 | 2.8 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.4 | 8.5 | GO:0043426 | MRF binding(GO:0043426) |
1.4 | 4.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.4 | 15.5 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
1.4 | 12.6 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
1.4 | 8.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.4 | 5.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.4 | 1.4 | GO:1990405 | protein antigen binding(GO:1990405) |
1.4 | 4.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.4 | 4.1 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
1.4 | 4.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.4 | 6.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.3 | 17.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.3 | 12.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.3 | 11.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.3 | 13.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.3 | 5.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.3 | 3.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.2 | 7.4 | GO:0050733 | RS domain binding(GO:0050733) |
1.2 | 9.7 | GO:0035174 | histone serine kinase activity(GO:0035174) |
1.2 | 3.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.2 | 5.9 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
1.2 | 3.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.1 | 4.6 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.1 | 9.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.1 | 12.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
1.1 | 3.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
1.1 | 1.1 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
1.1 | 4.3 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.1 | 8.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
1.1 | 18.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.0 | 5.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.0 | 2.1 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
1.0 | 2.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
1.0 | 7.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
1.0 | 3.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.0 | 4.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
1.0 | 4.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.0 | 15.8 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
1.0 | 6.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
1.0 | 12.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.0 | 2.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.0 | 5.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.0 | 2.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.9 | 13.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.9 | 8.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.9 | 7.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.9 | 5.6 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.9 | 2.8 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.9 | 5.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.9 | 2.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.9 | 0.9 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.9 | 9.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.9 | 11.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.9 | 0.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.9 | 0.9 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.9 | 6.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.9 | 8.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.9 | 3.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.9 | 6.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.9 | 2.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.9 | 2.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.9 | 1.8 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.9 | 4.4 | GO:0035473 | lipase binding(GO:0035473) |
0.9 | 4.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.9 | 3.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.9 | 5.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.9 | 12.9 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.9 | 2.6 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.8 | 4.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.8 | 2.5 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.8 | 11.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.8 | 2.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.8 | 2.4 | GO:0071253 | connexin binding(GO:0071253) |
0.8 | 9.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.8 | 3.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.8 | 3.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.8 | 3.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 6.4 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.8 | 2.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.8 | 3.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.8 | 6.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.8 | 1.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.8 | 6.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.8 | 3.1 | GO:0002046 | opsin binding(GO:0002046) |
0.8 | 4.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.7 | 12.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.7 | 2.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.7 | 3.7 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.7 | 1.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.7 | 2.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.7 | 2.9 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.7 | 0.7 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.7 | 1.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.7 | 2.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.7 | 9.9 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.7 | 8.4 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.7 | 4.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.7 | 2.8 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.7 | 2.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.7 | 2.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.7 | 5.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.7 | 5.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.7 | 2.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.7 | 3.4 | GO:0005534 | galactose binding(GO:0005534) |
0.7 | 1.4 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.7 | 3.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.7 | 18.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.7 | 3.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.7 | 1.3 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.7 | 0.7 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.7 | 3.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.7 | 5.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 9.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.6 | 1.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.6 | 21.1 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.6 | 1.9 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.6 | 15.0 | GO:0030552 | cAMP binding(GO:0030552) |
0.6 | 0.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.6 | 6.1 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.6 | 4.2 | GO:0034865 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.6 | 2.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.6 | 1.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.6 | 5.4 | GO:0035173 | histone kinase activity(GO:0035173) |
0.6 | 2.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.6 | 1.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.6 | 1.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.6 | 8.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.6 | 1.8 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.6 | 7.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 28.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.6 | 17.9 | GO:0043738 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.6 | 8.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.6 | 23.7 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.6 | 5.1 | GO:0001848 | complement binding(GO:0001848) |
0.6 | 5.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.6 | 4.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.6 | 10.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.6 | 10.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.6 | 7.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.5 | 1.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.5 | 11.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.5 | 2.7 | GO:0052759 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.5 | 8.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.5 | 1.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 2.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 2.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 1.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.5 | 1.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.5 | 14.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.5 | 4.8 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.5 | 6.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.5 | 1.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.5 | 3.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 1.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.5 | 1.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 3.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.5 | 8.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.5 | 6.3 | GO:0019176 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.5 | 1.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 3.6 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.5 | 2.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.5 | 4.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.5 | 2.0 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.5 | 2.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.5 | 8.5 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 3.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.5 | 5.5 | GO:0009975 | cyclase activity(GO:0009975) |
0.5 | 2.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 1.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.5 | 1.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.5 | 3.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 0.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.5 | 2.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.5 | 6.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.5 | 9.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.5 | 3.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.5 | 1.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.5 | 4.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.5 | 8.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.5 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.5 | 0.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.5 | 4.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.5 | 11.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.5 | 6.5 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 1.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.5 | 3.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.5 | 1.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.5 | 1.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.5 | 1.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.5 | 4.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 0.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.4 | 1.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 2.7 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.4 | 16.0 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.4 | 25.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.4 | 1.8 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.4 | 0.9 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 0.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.4 | 4.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.4 | 2.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 5.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 3.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 6.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 3.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 1.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.4 | 1.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 2.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.4 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 1.7 | GO:0097001 | ceramide binding(GO:0097001) |
0.4 | 6.3 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.4 | 1.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.4 | 1.3 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.4 | 11.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.4 | 3.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.4 | 2.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 8.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.4 | 11.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.4 | 2.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 9.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.4 | 1.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 4.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 1.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.4 | 0.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 2.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 10.0 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.4 | 2.0 | GO:0033265 | choline binding(GO:0033265) |
0.4 | 18.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.4 | 12.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.4 | 1.6 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.4 | 4.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 1.2 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 0.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.4 | 3.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 1.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.4 | 1.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 4.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 8.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.4 | 1.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.4 | 1.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 1.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.4 | 1.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.4 | 3.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.4 | 1.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 64.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 1.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 4.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 1.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 2.2 | GO:0070990 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
0.4 | 1.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) calcium:cation antiporter activity(GO:0015368) |
0.4 | 1.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.4 | 6.6 | GO:0000252 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.4 | 1.1 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.4 | 1.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 3.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 3.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.4 | 0.4 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 1.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 12.3 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.4 | 1.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.4 | 0.7 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.4 | 0.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.4 | 1.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.4 | 31.3 | GO:0015405 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.3 | 6.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 1.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 10.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 5.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 1.4 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 1.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 1.7 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 1.0 | GO:0070403 | NAD+ binding(GO:0070403) |
0.3 | 1.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.3 | 0.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 5.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.3 | 0.7 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 3.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 0.7 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 3.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 2.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 23.0 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.3 | 8.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 1.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 1.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 1.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 2.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.3 | 2.9 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 6.5 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 10.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 0.3 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.3 | 5.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.3 | 1.0 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 19.8 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.3 | 0.6 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 0.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 0.9 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.3 | 0.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 1.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 2.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.3 | 6.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 0.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 3.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 3.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 6.2 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.3 | 3.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 1.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 2.8 | GO:0043864 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.3 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 3.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.3 | 1.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 1.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 1.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.3 | 2.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 5.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 0.9 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 0.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.3 | 11.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 2.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 24.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 8.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.3 | 0.9 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.3 | 1.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 5.9 | GO:0017069 | snRNA binding(GO:0017069) |
0.3 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 8.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 5.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 2.3 | GO:0034891 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 0.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 0.9 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 11.8 | GO:0019003 | GDP binding(GO:0019003) |
0.3 | 2.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 2.8 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.3 | 10.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 1.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 0.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.3 | 2.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 6.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.3 | 0.8 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.3 | 0.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 3.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.3 | 1.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 8.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 0.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 0.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 3.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 3.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 1.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 5.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.3 | 4.5 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.3 | 5.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 5.6 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.3 | 1.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 3.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 0.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.3 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 2.6 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.3 | 0.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 1.3 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.3 | 0.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 26.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 1.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 12.6 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.3 | 0.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 1.0 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 1.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 0.2 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.2 | 1.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 3.9 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 3.7 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 0.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 1.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 5.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 1.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 1.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 0.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 4.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 0.2 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 4.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 3.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 2.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 2.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.2 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 0.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 7.3 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 4.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 1.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 4.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.4 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 2.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.7 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 0.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 5.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 4.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 1.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 2.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 2.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 2.9 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 0.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 8.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 0.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.9 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 0.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 0.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 2.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 1.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.2 | 1.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 0.6 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 0.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 20.1 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 23.9 | GO:0003729 | mRNA binding(GO:0003729) |
0.2 | 0.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 3.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 7.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 1.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 0.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 1.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.8 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 10.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 1.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.4 | GO:0060229 | lipase activator activity(GO:0060229) |
0.2 | 7.2 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 0.4 | GO:0016151 | nickel cation binding(GO:0016151) |
0.2 | 1.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.6 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.4 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 3.9 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.2 | 2.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 0.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.6 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 1.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 6.4 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.2 | 4.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 1.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 2.9 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 2.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 0.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 1.1 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 4.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 0.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 2.5 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.2 | 1.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 0.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 0.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 1.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 1.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 0.2 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.2 | 3.0 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 18.8 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 0.7 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 10.6 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 3.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 1.0 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 2.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 3.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 3.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 5.2 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 0.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.5 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 0.8 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 1.5 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.2 | 5.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 0.2 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 0.3 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.2 | 0.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 1.3 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 1.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 2.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 3.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.5 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.2 | 0.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 28.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 0.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 0.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 0.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 0.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 2.9 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 4.6 | GO:0019842 | vitamin binding(GO:0019842) |
0.2 | 17.6 | GO:0015631 | tubulin binding(GO:0015631) |
0.2 | 0.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 1.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.9 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.9 | GO:0042300 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 1.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.9 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 1.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) type II activin receptor binding(GO:0070699) |
0.1 | 0.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 2.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.5 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 4.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.9 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.4 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 2.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.3 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 9.2 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 2.8 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 7.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.9 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 7.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 1.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 44.7 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 11.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 1.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.7 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.1 | 0.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.4 | GO:0015114 | sodium:phosphate symporter activity(GO:0005436) phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 3.9 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.6 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.4 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 2.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 1.7 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 1.6 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 2.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.8 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 1.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 4.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 2.6 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.4 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.8 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 1.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 6.2 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 9.5 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.5 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.2 | GO:0019840 | isoprenoid binding(GO:0019840) |
0.1 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.1 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 2.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.2 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.1 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 1.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 1.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.7 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 4.0 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 1.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 1.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.2 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 10.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.4 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.3 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.1 | 4.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.1 | GO:0043176 | amine binding(GO:0043176) |
0.1 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.1 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.1 | 0.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.5 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.6 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 3.1 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 1.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 1.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.6 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.9 | GO:0008514 | organic anion transmembrane transporter activity(GO:0008514) |
0.1 | 5.9 | GO:0016791 | phosphatase activity(GO:0016791) |
0.1 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 7.7 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 30.1 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.1 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.1 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 4.9 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 0.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.7 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 0.3 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.7 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 1.0 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.2 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.0 | 0.1 | GO:0005501 | retinoid binding(GO:0005501) |
0.0 | 0.5 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.0 | GO:0019153 | peptide disulfide oxidoreductase activity(GO:0015037) protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.0 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.0 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.0 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 0.0 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.4 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 0.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.5 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.2 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.0 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.0 | 0.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.0 | 0.3 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.4 | GO:1901476 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.0 | GO:0089720 | death effector domain binding(GO:0035877) caspase binding(GO:0089720) |
0.0 | 0.0 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.0 | 0.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.1 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.1 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.0 | 0.0 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.0 | 0.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.0 | GO:0016726 | aldehyde oxidase activity(GO:0004031) xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 2.2 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.0 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 12.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 57.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.9 | 9.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.9 | 12.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.9 | 7.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.9 | 13.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.8 | 23.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.8 | 11.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.7 | 1.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.7 | 14.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.7 | 6.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.7 | 34.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.6 | 5.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 8.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.6 | 1.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.6 | 18.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.6 | 25.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.5 | 18.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.5 | 4.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.5 | 108.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.5 | 5.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 33.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.5 | 9.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 8.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.5 | 15.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.5 | 5.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.5 | 13.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 17.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 8.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 16.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 5.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 2.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.4 | 9.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.4 | 4.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 4.8 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.4 | 1.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.4 | 0.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.4 | 2.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 4.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 5.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 7.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 10.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 3.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 11.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 4.5 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 2.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 1.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 6.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 4.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 10.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 2.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 5.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 4.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 6.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 1.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 9.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 2.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 2.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 9.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.3 | 2.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.3 | 1.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 3.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 5.5 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 1.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 6.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 0.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 6.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 1.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 1.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 1.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 3.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 1.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 2.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 3.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 1.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 0.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 1.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 1.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 1.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 2.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 2.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 0.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 1.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 4.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 4.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 2.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 0.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 6.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 2.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 3.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 4.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 6.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 1.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 22.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 2.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 4.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 4.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 2.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 0.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 1.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 1.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 3.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 2.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 4.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.2 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 3.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.7 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 2.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.0 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 21.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
2.5 | 2.5 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
2.4 | 23.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.9 | 33.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.7 | 31.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.7 | 25.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.7 | 31.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
1.7 | 16.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.6 | 11.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.6 | 18.9 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
1.5 | 23.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.4 | 26.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.2 | 1.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
1.2 | 11.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.2 | 11.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.1 | 13.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.1 | 11.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.1 | 17.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.1 | 5.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.0 | 17.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.0 | 10.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.0 | 7.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.9 | 10.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.9 | 21.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.9 | 16.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.9 | 19.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.9 | 3.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.8 | 15.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.8 | 9.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.8 | 6.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.8 | 9.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.8 | 19.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.8 | 7.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.8 | 14.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.7 | 8.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.7 | 6.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.7 | 8.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.7 | 1.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.7 | 9.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.7 | 12.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.7 | 3.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.6 | 7.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.6 | 7.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.6 | 7.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.6 | 4.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.6 | 11.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.6 | 10.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.6 | 0.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.6 | 16.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.6 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.6 | 4.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.6 | 6.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.6 | 2.4 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.6 | 3.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.6 | 6.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.6 | 4.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.6 | 10.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 9.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 14.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.6 | 1.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 6.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.5 | 20.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.5 | 4.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 5.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 23.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.5 | 13.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 7.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 13.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 7.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.5 | 7.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 5.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.5 | 48.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.5 | 1.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.5 | 1.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.5 | 2.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.4 | 7.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.4 | 3.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.4 | 9.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.4 | 5.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 2.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 8.3 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.4 | 4.6 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.4 | 4.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.4 | 37.7 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.4 | 64.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 1.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 2.7 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.4 | 1.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.4 | 1.5 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.4 | 1.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 8.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.4 | 3.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 3.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.4 | 4.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 0.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 0.3 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.3 | 8.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 22.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 7.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 16.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.3 | 5.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 4.7 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.3 | 3.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 28.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 3.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 1.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 9.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 2.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 3.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 14.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.3 | 7.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.3 | 16.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 1.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.3 | 8.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 2.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 1.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 4.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 4.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 7.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 3.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 1.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 3.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 2.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 2.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 0.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 3.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 2.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 3.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 1.8 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 0.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 4.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 1.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 4.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 1.4 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 2.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 5.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 2.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.2 | 4.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 1.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 1.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 6.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 1.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 1.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 5.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 2.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 2.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 3.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 1.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 2.8 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.2 | 0.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 0.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 0.6 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 3.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 1.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 1.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 0.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 2.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 0.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 0.5 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.2 | 2.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 0.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 3.4 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 0.5 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.2 | 4.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 1.6 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.2 | 0.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 1.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 9.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 1.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 19.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 2.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 1.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 2.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 2.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 4.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 3.1 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 2.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.8 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 1.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 1.0 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.1 | 0.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 3.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 1.8 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 2.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.5 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 0.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 3.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 3.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.2 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 1.3 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 2.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 2.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 2.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.9 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 2.0 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 4.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.2 | REACTOME IMMUNE SYSTEM | Genes involved in Immune System |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 5.4 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 0.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.3 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.0 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.0 | 0.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.8 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.2 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 1.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 2.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.1 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.3 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.2 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.0 | 0.0 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.2 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.0 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.4 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.0 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |